Pure Global
NCT05418439

Study to Evaluate the Efficacy of Poppi Apple Cider Vinegar Prebiotic Soda to Improve Gut Health In Participants

Drink Poppi·ClinicalTrials.gov·dietary supplementCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
IBS - Irritable Bowel Syndrome
Drug/Device/Intervention
Drink Poppi Soda
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Drink Poppi
Location
Santa Monica, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2022
End date
May 01, 2022
Enrollment
38 participants
Primary outcome

Change in IBS symptoms [Time Frame: Baseline to 4 weeks),Change in bowel movements [Time Frame: Baseline to 4 weeks),Change in skin health [Time Frame: Baseline to 4 weeks)

Summary

This exploratory observational trial provides the opportunity to gather information on the
 effect of daily consumption of Poppi Apple Cider Vinegar Prebiotic Soda on gut health and
 digestion.

ICD-10 classifications
Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndromeIrritable bowel syndrome with predominant diarrhoea [IBS-D]Irritable bowel syndrome with mixed bowel habits [IBS-M]Other and unspecified irritable bowel syndrome
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05418439
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05418439 through Pure Global AI's free database. This phase not specified trial is sponsored by Drink Poppi and is currently Completed. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 38 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.